Eculizumab improves fatigue in refractory generalized myasthenia gravis
Eculizumab improves fatigue in refractory generalized myasthenia gravis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Eculizumab improves fatigue in refractory generalized myasthenia gravis have?
Eculizumab improves fatigue in refractory generalized myasthenia gravis has 58 citations in the OpenAlex counts ScholarIQ stores.
When was Eculizumab improves fatigue in refractory generalized myasthenia gravis published?
Eculizumab improves fatigue in refractory generalized myasthenia gravis has 2019 year in the ScholarIQ index.
What is the open-access status of Eculizumab improves fatigue in refractory generalized myasthenia gravis?
Eculizumab improves fatigue in refractory generalized myasthenia gravis has hybrid oa status in the ScholarIQ index.
What is the DOI of Eculizumab improves fatigue in refractory generalized myasthenia gravis?
The DOI for Eculizumab improves fatigue in refractory generalized myasthenia gravis is on the source record.
What is the PMID of Eculizumab improves fatigue in refractory generalized myasthenia gravis?
The PMID for Eculizumab improves fatigue in refractory generalized myasthenia gravis is on the source record.
What is the OpenAlex record for Eculizumab improves fatigue in refractory generalized myasthenia gravis?
The OpenAlex for Eculizumab improves fatigue in refractory generalized myasthenia gravis is on the source record.